JBNB  Vol.2 No.5 , December 2011
As Could We Assure Safety in Large-Scale Manufacturing of Nanoparticles for the Biomedical Use
Abstract: Nanoparticles provide great advantages but also great risks. Risks associating with nanoparticles are the problem of all technologies, but they increase in many times in nanotechnologies. Adequate methods of outgoing production inspection are necessary to solve the problem of risks, and the inspection must be based on the safety standard. Existing safety standard results from a principle of “maximum permissible concentrations or MPC”. This principle is not applicable to nanoparticles, but a safety standard reflecting risks inherent in nanoparticles doesn’t exist. Essence of the risks is illustrated by the example from pharmacology, since its safety assurance is conceptually based on MPC and it has already come against this problem. Possible formula of safety standard for nanoparticles is reflected in many publications, but conventional inspection methods cannot provide its realization, and this gap is an obstacle to assumption of similar formulas. Therefore the development of nanoparticle industry as a whole (also development of the pharmacology in particular) is impossible without the creation of an adequate inspection method. There are suggested new inspection methods founded on the new physical principle and satisfying to the adequate safety standard for nanoparticles. These methods demonstrate that creation of the adequate safety standard and the outgoing production inspection in a large-scale manufacturing of nanoparticles are the solvable problems. However there is a great distance between the physical principle and its hardware realization, and a transition from the principle to the hardware demands great intellectual and material costs. Therefore it is desirable to call attention of the public at large to the necessity of urgent expansions of investigations associated with outgoing inspections in nanoparticles technologies. It is necessary also to attract attention, first, of representatives of state structures controlling approvals of the adequate safety standard to this problem, since it is impossible to compel producers providing the safety without the similar standard, and, second, of leaders of pharmacological industry, since their industry already entered into the nanotechnology era, and they have taken an interest in a forthcoming development of inspection methods.
Cite this paper: nullMaksimov, K. , Maksimov, S. and Soukhov, N. (2011) As Could We Assure Safety in Large-Scale Manufacturing of Nanoparticles for the Biomedical Use. Journal of Biomaterials and Nanobiotechnology, 2, 601-613. doi: 10.4236/jbnb.2011.225072.

[1]   S. Zuin, G. Pojana and A. Marcomini, “Effect-Oriented Physicochemical Characterization of Nanomaterials,” In: N. Montairo-Riviere and L. C. Tran, Eds., Nanotechnology. Characterization, Dosing and Health Effects, Informa Healthcare USA, Inc, 2007, pp. 19-58.

[2]   A. S. Barnard, “Modelling of Nanoparticles: Approaches to Morphology and Evolution,” Reports on Progress in Physics, Vol. 73, No. 8, 2010, pp. 86502-86553. doi:10.1088/0034-4885/73/8/086502

[3]   S. K. Maksimov and K. S. Maksimov, “Controlling the Surface Functionality of Nanomaterials,” Nanotechnologies in Russia, Vol. 4, No. 3-4, 2009, pp. 188-200. doi:10.1134/S1995078009030070

[4]   S. K. Maksimov and K. S. Maksimov, “Problem of Safety in Nanoparticle Mass Production and Its Solution by Means of Advanced Scanning Electron Microscopy,” Journal of Physics: Conference Series, Vol. 291, No. 1, 2011, Article ID 012014. doi:10.1088/1742-6596/291/1/012014.

[5]   W. C. W. Chan (Ed.), “Bio-Applications of Nanoparticles (Advances in Experimental Medicine and Biology),” Springer, Berlin, 2010.

[6]   M. Loizidou and A. M. Seifalian, “Nanotechnology and Its Applications in Surgery,” British Journal of Surgery, Vol. 97, 2010, pp. 463-465. doi:10.1002/bjs.7074

[7]   A. S. Manmode, D. M. Sakarkar and N. M. Mahajan, “Nanoparticles-Tremendous Therapeutic Potential. A Review,” International Journal of PharmTech Research, Vol. 1, No. 4, 2009, pp. 1020-1027.

[8]   S. E. McNeil (Ed.), “Characterization of Nanoparticles Intended for Drug Delivery Series: Methods in Molecular Biology,” Vol. 697, Humana Press, Springer, Berlin, 2011.

[9]   Ya. M. Ram, H. K. S. Yadav, M. N. Singh and H. G. Shivakumar, “Nanoparticles, Promising Carriers in Drug Targeting: A Review,” Current Drug Therapy, Vol. 6, No. 2, 2011, pp. 87-96. doi:10.2174/157488511795304958

[10]   R. Ravichandran, “Physico-Chemical Evaluation of Gymnemic Acids Nanocrystals,” International Journal of Nanoparticles, Vol. 3, 2010, pp. 280-296. doi:10.1504/IJNP.2010.035882

[11]   K. Kazuo, “Nanomaterials May Call for a Reconsideration of the Present Japanese chemical Regulatory System,” Clean Technologies and Environmental Policy, Vol. 8, No. 4, 2006, pp. 251-259. doi:10.1007/s10098-006-0060-9

[12]   L. L. Ma, J. F. Zhao, J. Wang, J. Liu, Y. M. Duan, H. T. Liu, N. Li, J. Ruan, H. Wang and F. S. Hong, “The Acute Liver Injury in Mice Caused by Nano-Anatase TiO2,” Nanoscale Research Letters, No. 4, 2009, pp. 1275-1285.

[13]   C. M. Sayes and D. B. Warheit, “An in Vitro Investigation of the Differential Cytotoxic Responses of Human and Rat Lung Epithelial Cell Lines Using TiO2 Nanoparticles,” International Journal of Nanotechnology, Vol. 5, No. 1, 2008, pp. 15-29. doi:10.1504/IJNT.2008.016548

[14]   F. Yang, F. S. Hong, W. J. You, F. Gao, C. Wu and P. Yang, “Influences of Nano-Anatase TiO2 on the Nitrogen Metabolism of Growing Spinach,” Biological Trace Element Research, Vol. 110, No. 2, 2006, pp. 179-190. doi:10.1385/BTER:110:2:179

[15]   I. Cavero, “Safety Pharmacology Society: 9th Annual Meeting,” Expert Opinion on Drug Safety, Vol. 9, No. 2, 2010, pp. 365-378. doi:10.1517/14740331003625577

[16]   J. C. Marijnissen and L. Gradon (Eds.), “Nanoparticles in Medicine and Environment Inhalation and Health Effects,” Springer, Berlin, 2010.

[17]   K. Donaldson. “Resolving the Nanoparticles Paradox,” Nanomedicine, Vol. 1, No. 2, 2006, pp. 229-234. doi:10.2217/17435889.1.2.229

[18]   J. Hutchison, A. Kirkland (Eds.), “Nanocharacterization,” RSC Publishing, London, 2007.

[19]   B. Bhushan and O. Marti, “Scanning Probe Microscopy —Principle of Operation. Instrumentation and Probes,” In: B. Bhushan, Ed., Springer Handbook of Nanotechnology, 2nd Edition, Springer, Berlin, pp. 239-278.

[20]   D. E. Newbury, D. C. Joy, P. Echin, C. E. Fiory and J. I. Goldstein, “Advanced Scanning Electron Microscopy and X-Ray Microanalysis,” Plenum Press, New York, 2003.

[21]   S. K. Maksimov and K. S. Maksimov, “Concept of Safety Standard and Outgoing Inspection in Technologies of Nanoparticles,” Nanotechnics, No 18. 2009, pp. 5-12 (in Russian).

[22]   R. Vidya, “Minimum Variance and VOQL Chain Sampling Plans-ChSP-4(c1, c2),” Communications in Statistics: Simulation and Computation, Vol. 37, No. 7, 2008, pp. 1466-1478. doi:10.1080/03610910601096585

[23]   D. J. Dingley and M. M. Nowell, “The Use of Electron Backscatter Diffraction for the Investigation of Nano Crystalline Materials and the Move towards Orientation Imaging in the TEM,” Microchimica Acta, Vol. 147, No. 3, 2004, pp. 157-165. doi:10.1007/s00604-004-0186-6

[24]   M. J. Carr, C. E. Lyman and J. M. Cowley, “Identification of Unknowns in Electron Diffraction,” In: J. M. Cowley, Ed., Electron Diffraction Technique, Vol. 1, Oxford University Press, Oxford, 992, pp. 212-216.

[25]   B. Minnich, H. Leeb, E. W. N. Bernroider and A. Lamerschwandtner, “Three-Dimensional Morphometry in Scanning Electron Microscopy: A Technique for Accurate Dimensional And Angular Measurements of Microstructures Using Stereopaired Digitized Images and Digital Image Analysis,” Journal of Microscopy, Vol. 195, No. 1, 1999, pp. 23-33. doi:10.1046/j.1365-2818.1999.00478.x

[26]   M. I. Ilyin, A. I. Kozlitin, S. K. Maksimov, A. V. Nikitin, and V. V. Bannikov, “High Accuracy and Precision Measurements of Line Dimensions of Sub-0.25-Micron and Nanometer Objects in Scanning Electron Microscopy,” Scanning, Vol. 19, 1997, pp. 224-225.

[27]   A. Zlotnik, Sh. Ben-Yaish and Z. Zalevski, “Extending of the Depth of Focus for Enhanced Three-Dimensional Image and Profilometry: An Overview,” Applied Optics, Vol. 48, No. 34, 2009, pp. H105-H112. doi:10.1364/AO.48.00H105

[28]   K. S. Maksimov, “Systematic Features of Defocused Images in Scanning Electron Microscopy and Nanoscale size Measurements,” Semiconductors, Vol. 43, No. 13, 2009, pp. 1725-1727. doi:10.1134/S1063782609130235

[29]   S. K. Maksimov and K.S. Maksimov, “New approach in metrology for nanotechnologies,” Technical Physics Letters, Vol. 35, No. 10, 2010, pp. 938-941. doi:10.1134/S1063785010100196

[30]   S. K. Maksimov and K. S. Maksimov, “Control over the Morphology of Nanoobjects and a New Way to Accomplish It,” Bulletin of the Russian Academy of Sciences. Physics, Vol. 75, No. 9, Allerton Press, Inc, 2011, pp. 1171-1175.

[31]   B. K. Vainstein, B. B. Zvyagin and A. S. Avilov, “Electron Diffraction Structure Analysis,” In: M. J. Cowley, Ed., Electron Diffraction Technique, Vol. 2, Oxford University Press, Oxford, 1992.

[32]   A. S. Barnard, R. R. Yeredla and H. Xu, “Modelling the Effect of Particle Shape on the Phase Stability of ZrO2 Nanoparticles,” Nanotechnology, Vol. 17, No. 6, 2006, pp. 3039-3047. doi:10.1088/0957-4484/17/12/038

[33]   G. Guisbiers, G. Abudukelimu, F. Clement and M. Wautelet. “Effects of Shape on the Phase Stability of Nanoparticles,” Journal of Computational and Theoretical Nano-science, Vol. 4, No. 2, 2007, pp. 309-315.

[34]   Z. G. Pinsker, “Electron Diffraction,” Butterworth, London, 1949.

[35]   T. Kawasaki, Y. Yoshida, H. Ose and H. Todokoro, “Electron Beam Apparatus with Aberration Corrector,” US Patent 7199365, 2007.

[36]   H. Kitsuki, K. Aoki and M. Sato, “Scanning Electron Microscope,” US Patent 7442929, 2008.

[37]   J. V. Lauritsen, Ja. Kibsgaard, S. Helveg, H. Topsoe, B. S. Clausen, E. L?gsgaard and F. Besenbacher, “Size-Dependent Structure of MoS2 Nanocrystals,” Nature Nano-technology, Vol. 2, No. 1, 2007, pp. 53-58. doi:10.1038/nnano.2006.171